305 related articles for article (PubMed ID: 22639158)
21. Cell- and peptide-based immunotherapeutic approaches for glioma.
Yamanaka R
Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cell-based immunotherapy for malignant gliomas.
Akasaki Y; Black KL; Yu JS
Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
[TBL] [Abstract][Full Text] [Related]
23. Cancer immunoediting in malignant glioma.
Dunn GP; Fecci PE; Curry WT
Neurosurgery; 2012 Aug; 71(2):201-22; discussion 222-3. PubMed ID: 22353795
[TBL] [Abstract][Full Text] [Related]
24. The role of tregs in glioma-mediated immunosuppression: potential target for intervention.
Humphries W; Wei J; Sampson JH; Heimberger AB
Neurosurg Clin N Am; 2010 Jan; 21(1):125-37. PubMed ID: 19944972
[TBL] [Abstract][Full Text] [Related]
25. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
[TBL] [Abstract][Full Text] [Related]
26. Peptide vaccine.
Izumoto S
Adv Exp Med Biol; 2012; 746():166-77. PubMed ID: 22639167
[TBL] [Abstract][Full Text] [Related]
27. Galectin-1 and immunotherapy for brain cancer.
Verschuere T; De Vleeschouwer S; Lefranc F; Kiss R; Van Gool SW
Expert Rev Neurother; 2011 Apr; 11(4):533-43. PubMed ID: 21469926
[TBL] [Abstract][Full Text] [Related]
28. Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model.
Grauer OM; Sutmuller RP; van Maren W; Jacobs JF; Bennink E; Toonen LW; Nierkens S; Adema GJ
Int J Cancer; 2008 Apr; 122(8):1794-802. PubMed ID: 18076066
[TBL] [Abstract][Full Text] [Related]
29. The role of regulatory T-cells in glioma immunology.
Ooi YC; Tran P; Ung N; Thill K; Trang A; Fong BM; Nagasawa DT; Lim M; Yang I
Clin Neurol Neurosurg; 2014 Apr; 119():125-32. PubMed ID: 24582432
[TBL] [Abstract][Full Text] [Related]
30. The role of microglia in central nervous system immunity and glioma immunology.
Yang I; Han SJ; Kaur G; Crane C; Parsa AT
J Clin Neurosci; 2010 Jan; 17(1):6-10. PubMed ID: 19926287
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of local immunoresistance in glioma.
Albesiano E; Han JE; Lim M
Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
[TBL] [Abstract][Full Text] [Related]
32. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
[TBL] [Abstract][Full Text] [Related]
33. [Brain tumor immunotherapy: Illusion or hope?].
Migliorini D; Dutoit V; Walker PR; Dietrich PY
Bull Cancer; 2017 May; 104(5):476-484. PubMed ID: 28318492
[TBL] [Abstract][Full Text] [Related]
34. Glioma stem cell research for the development of immunotherapy.
Xu Q; Yuan X; Yu JS
Adv Exp Med Biol; 2012; 746():216-25. PubMed ID: 22639171
[TBL] [Abstract][Full Text] [Related]
35. Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model.
Chirasani SR; Leukel P; Gottfried E; Hochrein J; Stadler K; Neumann B; Oefner PJ; Gronwald W; Bogdahn U; Hau P; Kreutz M; Grauer OM
Int J Cancer; 2013 Feb; 132(4):843-53. PubMed ID: 22752934
[TBL] [Abstract][Full Text] [Related]
36. Cellular immunity in the treatment of brain tumors.
Wheeler CJ; Yu JS; Black KL
Clin Neurosurg; 2004; 51():132-9. PubMed ID: 15571138
[No Abstract] [Full Text] [Related]
37. [Antitumor immune response: what are the roles for gliomas?].
Dietrich PY
Rev Neurol (Paris); 2001 Nov; 157(11 Pt 1):1339-48. PubMed ID: 11924003
[TBL] [Abstract][Full Text] [Related]
38. Concepts in glioma immunotherapy.
Platten M; Bunse L; Wick W; Bunse T
Cancer Immunol Immunother; 2016 Oct; 65(10):1269-75. PubMed ID: 27460064
[TBL] [Abstract][Full Text] [Related]
39. Harnessing the immune system against human glioma.
Dhodapkar KM; Banerjee D; Steinman RM
Ann N Y Acad Sci; 2005 Dec; 1062():13-21. PubMed ID: 16461784
[TBL] [Abstract][Full Text] [Related]
40. The role of regulatory T cells in malignant glioma.
Sonabend AM; Rolle CE; Lesniak MS
Anticancer Res; 2008; 28(2B):1143-50. PubMed ID: 18505050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
